-
公开(公告)号:US20240401082A1
公开(公告)日:2024-12-05
申请号:US18607056
申请日:2024-03-15
Applicant: Genzyme Corporation
Inventor: Matthew Adamowicz , Hao Chen , Amy Frederick , Christian Mueller , Catherine O’Riordan , Vaishnavi Rajagopal , John C. Reed , Michael John Storek
IPC: C12N15/864 , A61K9/00 , A61K31/711 , A61P27/02
Abstract: The present disclosure provides gene therapy that targets complement pathways for treating dry age-related macular degeneration.